Wiki

Ankle-Brachial Index (ABI) Doppler Study

Ankle-Brachial Index (ABI) Doppler Study — 2022-11-25

Facility: Jothydev's Diabetes & Research Centre, Mudavanmugal, Thiruvananthapuram
OP No: 4096
Patient age at time of study: 74 years
Consulting physician: Dr. Jothydev Kesavadev MD
Consultant on report: Not recorded

Study Details

ABI Doppler performed as part of diabetic foot screening. Bilateral ankle and brachial pressures measured.

Measurements

Parameter Right Left Interpretation
Brachial BP 130 mmHg 130 mmHg Symmetric
Dorsalis Pedis pressure 120 / 100 / 90 mmHg 120 / 100 / 90 mmHg Triphasic signal
AB Index (ABI) 0.92 0.92 Normal (TASC II: 0.91–1.40)
TB Index (TBI) 0.69 0.69 Borderline (threshold: >0.70 = normal, ≤0.70 = abnormal)

TASC II Reference Guidelines

ABI Range Classification
0.91–1.40 Normal
0.71–0.90 Mild PAD
0.41–0.70 Moderate PAD
<0.40 Severe PAD
>1.40 Incompressible (calcified) artery
TBI Classification
>0.70 Normal
≤0.70 Abnormal

Waveform Findings

  • Right Brachial: Multi-peak waveform, Gain 1
  • Left Brachial: Multi-peak waveform, Gain 1
  • Right Posterior Tibial: Waveform present
  • Left Posterior Tibial: Waveform present
  • Right Dorsalis Pedis: Waveform present
  • Left Dorsalis Pedis: Waveform present
  • Right Toe: Triphasic pattern, Gain 1
  • Left Toe: Normal waveform, Gain 1

Interpretation

Report conclusion: "Normal ABI study."

Borderline TBI — Clinically Significant in Diabetic Patient

ABI is within normal range bilaterally (0.92), but TBI = 0.69 is exactly at the abnormal threshold (≤0.70 = abnormal). In diabetic patients, TBI is often more reliable than ABI because calcified vessels can cause falsely elevated ABI. A borderline TBI of 0.69 in a 74-year-old diabetic patient suggests:
- Possible early distal arterial disease — the microvascular territory served by the toe arteries
- Despite normal ABI, toe perfusion may be at the lower limit of adequate
- Baseline established: any future TBI < 0.69 would represent worsening

Clinical context: This value should be monitored longitudinally. Combined with biothesiometry values (avg 29–33V) and the monofilament test (all intact), the overall foot risk assessment was low-moderate at this time.

Clinical Context

  • Performed as part of comprehensive diabetic foot screening at Jothydev's on 2022-11-25
  • Concurrent tests: Biothesiometry 2022 11 25, Monofilament 2022 11 25
  • HbA1c on same date: 5.8% (pre-diabetic range by facility standards)
  • Patient on insulin (Tresiba) + multiple oral antidiabetics at time of study
  • Note: Peripheral arterial status should be reassessed. No imaging records in vault post-2022.

Related Pages

Source: raw/assets/20260429_IMG_9749.jpeg